BRIEF-Roche Receives FDA Clearance With Clia Waiver For Cobas® Liat Molecular Tests

Jan 22 (Reuters) - ROCHE HOLDING AG ROG.S:

• ROCHE RECEIVES FDA CLEARANCE WITH CLIA WAIVER FOR COBAS® LIAT MOLECULAR TESTS TO DIAGNOSE SEXUALLY TRANSMITTED INFECTIONS AT THE POINT OF CARE

• ROCHE HOLDING AG - FDA GRANTS 510(K) CLEARANCE AND CLIA WAIVER FOR ROCHE'S COBAS LIAT STI PANELS

• ROCHE HOLDING AG - COBAS LIAT PANELS ENABLE DIAGNOSIS OF MULTIPLE STIS WITH SINGLE SAMPLE

• ROCHE HOLDING AG - COBAS LIAT STI TESTS TO BE AVAILABLE IN U.S. MARKET SOON

• ROCHE HOLDING AG - COBAS LIAT SYSTEM REDUCES CONTAMINATION RISKS

Source text: ID:nGNEflQVy

Further company coverage: ROG.S

(Gdansk Newsroom)

((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))